In yesterday’s Wall Street session, Asensus Surgical Inc (AMEX:ASXC) shares traded at $0.33, down -0.81% from the previous session.
ASXC stock price is now 29.81% away from the 50-day moving average and 21.67% away from the 200-day moving average. The market capitalization of the company currently stands at $89.87M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On September 08, 2022, Cantor Fitzgerald recently initiated its ‘Overweight’ rating on the stock quoting a target price of $1.50, while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, Starling William N JR, Director bought 18,134 shares of the company’s stock on Dec 14 ’23. The stock was bought for $5,078 at an average price of $0.28. Upon completion of the transaction, the Director now directly owns 39,134 shares in the company, valued at $12914.22. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 14 ’23, Director Starling William N JR sold 18,134 shares of the business’s stock. A total of $5,078 was realized by selling the stock at an average price of $0.28. A total of 2.02% of the company’s stock is owned by insiders.
During the past 12 months, Asensus Surgical Inc has had a low of $0.20 and a high of $0.65. As of last week, the company has a debt-to-equity ratio of 0.42, a current ratio of 1.00, and a quick ratio of 0.69. The fifty day moving average price for ASXC is $0.254 and a two-hundred day moving average price translates $0.2712 for the stock.
The latest earnings results from Asensus Surgical Inc (AMEX: ASXC) was released for 2024-03-31. The net profit margin was -902.25% and return on equity was -169.75% for ASXC. The company reported revenue of $1.12 million for the quarter, compared to $0.98 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.06 percent.
